{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:57:05Z","timestamp":1780567025505,"version":"3.54.1"},"reference-count":41,"publisher":"American Psychiatric Association Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2005,2,1]]},"DOI":"10.1176\/appi.ajp.162.2.361","type":"journal-article","created":{"date-parts":[[2005,1,27]],"date-time":"2005-01-27T23:18:39Z","timestamp":1106867919000},"page":"361-369","source":"Crossref","is-referenced-by-count":149,"title":["Additive Effects of HIV and Chronic Methamphetamine Use on Brain Metabolite Abnormalities"],"prefix":"10.1176","volume":"162","author":[{"given":"Linda","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Speck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Grob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1622CEGJBDDJ","unstructured":"Peltier R, Li D, Lytle D, Taylor C, Emmett-Oglesby M: Chronic d-amphetamine or methamphetamine produces cross-tolerance to the discriminative and reinforcing stimulus effects of cocaine. J Pharmacol Exp Ther 1996; 277:212\u2013218"},{"key":"R1622CEGCHFFF","unstructured":"Vongsheree S, Sri-Ngam P, Ruchusatsawat N, Thaisri H, Puangtabtim W, Phutiprawan T, Sawanpanyalert P: High HIV-1 prevalence among methamphetamine users in central Thailand, 1999\u20132000. J Med Assoc Thai 2001; 84:1263\u20131267"},{"key":"R1622CEGGEGDA","doi-asserted-by":"crossref","unstructured":"Molitor F, Ruiz J, Flynn N, Mikanda J, Sun R, Anderson R: Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse 1999; 25:475\u2013493","DOI":"10.1081\/ADA-100101874"},{"key":"R1622CEGJIJEF","doi-asserted-by":"crossref","unstructured":"Halkitis P, Parsons J, Stirratt M: A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J Homosex 2001; 41:17\u201335","DOI":"10.1300\/J082v41n02_02"},{"key":"R1622CEGIEDFI","doi-asserted-by":"crossref","unstructured":"Woody GE, VanEtten-Lee ML, McKirnan D, Donnell D, Metzger D, Seage G III, Gross M (HIVNET VPS 001 Protocol Team): Substance use among men who have sex with men: comparison with a national household survey. J Acquir Immune Defic Syndr 2001; 21:86\u201390","DOI":"10.1097\/00042560-200105010-00015"},{"key":"R1622CEGHJAGA","doi-asserted-by":"crossref","unstructured":"McKetin R, Mattick R: Attention and memory in illicit amphetamine users: comparison with non-drug-using controls. Drug Alcohol Depend 1998; 50:181\u2013184","DOI":"10.1016\/S0376-8716(98)00022-2"},{"key":"R1622CEGFGJFG","doi-asserted-by":"crossref","unstructured":"Simon S, Domier C, Sim T, Richardson K, Rawson R, Ling W: Cognitive performance of current methamphetamine and cocaine abusers. J Addict Dis 2002; 21:61\u201374","DOI":"10.1300\/J069v21n01_06"},{"key":"R1622CEGEADAF","doi-asserted-by":"crossref","unstructured":"Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ: Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 1996; 2:699\u2013703","DOI":"10.1038\/nm0696-699"},{"key":"R1622CEGCJDIG","doi-asserted-by":"crossref","unstructured":"McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA: Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography. J Neurosci 1998; 18:8417\u20138422","DOI":"10.1523\/JNEUROSCI.18-20-08417.1998"},{"key":"R1622CEGCBCJB","doi-asserted-by":"crossref","unstructured":"Volkow N, Chang L, Wang G-J, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding Y-S, Logan J, Wong C, Miller EN: Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001; 158:377\u2013382","DOI":"10.1176\/appi.ajp.158.3.377"},{"key":"R1622CEGBHBIC","doi-asserted-by":"crossref","unstructured":"Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido-Yee M, Miller E: Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res 2002; 114:65\u201379","DOI":"10.1016\/S0925-4927(02)00004-5"},{"key":"R1622CEGFHEEJ","doi-asserted-by":"crossref","unstructured":"Ernst T, Chang L, Leonido-Yee M, Speck O: Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 2000; 54:1344\u20131349","DOI":"10.1212\/WNL.54.6.1344"},{"key":"R1622CEGGHFFG","doi-asserted-by":"crossref","unstructured":"Sekine Y, Minabe Y, Kawai M, Suzuki K, Iyo M, Isoda H, Sakahara H, Ashby CJ, Takei N, Mori N: Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms: a proton MRS study. Neuropsychopharmacology 2002; 27:453\u2013461","DOI":"10.1016\/S0893-133X(02)00321-4"},{"key":"R1622CEGIEFGB","doi-asserted-by":"crossref","unstructured":"Meyerhoff DJ, MacKay S, Bachman L, Poole N, Dillon WP, Weiner MW, Fein G: Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 1993; 43:509\u2013515","DOI":"10.1212\/WNL.43.3_Part_1.509"},{"key":"R1622CEGDBGCI","doi-asserted-by":"crossref","unstructured":"Chang L, Ernst T, Witt M, Ames N, Jocivich J, Speck O, Gaiefsky M, Walot I, Miller E: Relationships among cerebral metabolites, cognitive function and viral loads in antiretroviral-naive HIV patients. Neuroimage 2002; 17:1638\u20131648","DOI":"10.1006\/nimg.2002.1254"},{"key":"R1622CEGCJBGB","doi-asserted-by":"crossref","unstructured":"Power C, Selnes OA, Grim JA, McArthur JC: HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:273\u2013278","DOI":"10.1097\/00042560-199503010-00008"},{"key":"R1622CEGHHGIA","doi-asserted-by":"crossref","unstructured":"Aronow HA, Brew BJ, Price RW: The management of the neurological complications of HIV infection and AIDS. AIDS 1988; 2:151\u2013159","DOI":"10.1097\/00002030-198800001-00023"},{"key":"R1622CEGJBCFJ","doi-asserted-by":"crossref","unstructured":"Ernst T, Chang L: Elimination of artifacts in short echo time 1H MR spectroscopy of the frontal lobe. Magn Reson Med 1996; 36:462\u2013468","DOI":"10.1002\/mrm.1910360320"},{"key":"R1622CEGIJBBC","doi-asserted-by":"crossref","unstructured":"Ernst T, Kreis R, Ross BD: Absolute quantitation of water and metabolites in the human brain, part I: compartments and water. J Magn Reson 1993; 102:1\u20138","DOI":"10.1006\/jmrb.1993.1055"},{"key":"R1622CEGCHECB","doi-asserted-by":"crossref","unstructured":"Kreis R, Ernst T, Ross BD: Absolute quantitation of water and metabolites in the human brain, part II: metabolite concentrations. J Magn Reson 1993; 102:9\u201319","DOI":"10.1006\/jmrb.1993.1056"},{"key":"R1622CEGHFAFG","doi-asserted-by":"crossref","unstructured":"Meyerhoff D, Bloomer C, Cardenas V, Norman D, Weiner M, Fein G: Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV plus patients. Neurology 1999; 52:995\u20131003","DOI":"10.1212\/WNL.52.5.995"},{"key":"R1622CEGFIIIB","doi-asserted-by":"crossref","unstructured":"Taylor M, Alhassoon O, Schweinsburg B, Videen J, Grant I (HNRC [HIV Neurobehavioral Research Center] Group, HIV Neurobehavioral Research Center): MR spectroscopy in HIV and stimulant dependence. J Int Neuropsychol Soc 2000; 6:83\u201385","DOI":"10.1017\/S1355617700611104"},{"key":"R1622CEGDHGAE","doi-asserted-by":"crossref","unstructured":"Maragos W, Young K, Turchan J, Guseva M, Pauly J, Nath A, Cass W: Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J Neurochem 2002; 83:955\u2013963","DOI":"10.1046\/j.1471-4159.2002.01212.x"},{"key":"R1622CEGBFIFA","doi-asserted-by":"crossref","unstructured":"Scheller C, Sopper S, Jassoy C, ter Meulen V, Riederer P, Koutsilieri E: Dopamine activates HIV in chronically infected T lymphoblasts. J Neural Transm 2000; 107:1483\u20131489","DOI":"10.1007\/s007020070012"},{"key":"R1622CEGBIEGI","unstructured":"Czub S, Koutsilieri E, Sopper S, Czub M, Stahl-Hennig C, Muller J, Pedersen V, Gsell W, Heeney J, Gerlach M, Gosztonyi G, Riederer P, ter Meulen V: Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs. Acta Neuropathol (Berl) 2001; 101:85\u201391"},{"key":"R1622CEGECGHH","doi-asserted-by":"crossref","unstructured":"Gavrilin M, Mathes L, Podell M: Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J Neurovirol 2002; 8:240\u2013249","DOI":"10.1080\/13550280290049660"},{"key":"R1622CEGBIAGE","doi-asserted-by":"crossref","unstructured":"Roth M, Tashkin D, Choi R, Jamieson B, Zack J, Baldwin G: Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J Infect Dis 2002; 185:701\u2013705","DOI":"10.1086\/339012"},{"key":"R1622CEGJFFDD","doi-asserted-by":"crossref","unstructured":"Chang L, Ernst T, Strickland T, Mehringer CM: Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users. Am J Psychiatry 1999; 156:716\u2013722","DOI":"10.1176\/ajp.156.5.716"},{"key":"R1622CEGFFFHA","doi-asserted-by":"crossref","unstructured":"Henry JA, Hill IR: Fatal interaction between ritonavir and MDMA (letter). Lancet 1998; 352:1751\u20131752","DOI":"10.1016\/S0140-6736(05)79824-X"},{"key":"R1622CEGHCGHC","doi-asserted-by":"crossref","unstructured":"Hales G, Roth N, Smith D: Possible fatal interaction between protease inhibitors and methamphetamine (letter). Antivir Ther 2000; 5:19","DOI":"10.1177\/135965350000500108"},{"key":"R1622CEGEIFJB","doi-asserted-by":"crossref","unstructured":"Nath A, Maragos W, Avison M, Schmitt F, Berger J: Acceleration of HIV dementia with methamphetamine and cocaine. J Neurovirol 2001; 7:66\u201371","DOI":"10.1080\/135502801300069737"},{"key":"R1622CEGIFEBJ","doi-asserted-by":"crossref","unstructured":"Brand A, Richter-Landsberg C, Leibfritz D: Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15:289\u2013298","DOI":"10.1159\/000111347"},{"key":"R1622CEGJHJCE","doi-asserted-by":"crossref","unstructured":"Hebert M, O\u2019Callaghan J: Protein phosphorylation cascades associated with methamphetamine-induced glial activation. Ann NY Acad Sci 2000; 914:238\u2013262","DOI":"10.1111\/j.1749-6632.2000.tb05200.x"},{"key":"R1622CEGIGCIF","doi-asserted-by":"crossref","unstructured":"Harvey D, Lacan G, Tanious S, Melega W: Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Res 2000; 871:259\u2013270","DOI":"10.1016\/S0006-8993(00)02439-2"},{"key":"R1622CEGEEEBB","doi-asserted-by":"crossref","unstructured":"Lee Y, Hennig B, Yao J, Toborek M: Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells. J Neurosci Res 2001; 66:583\u2013591","DOI":"10.1002\/jnr.1248"},{"key":"R1622CEGJHHGD","doi-asserted-by":"crossref","unstructured":"Bell J, Brettle R, Chiswick A, Simmonds P: HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS: effect of neocortical involvement. Brain 1998; 121(part 11):2043\u20132052","DOI":"10.1093\/brain\/121.11.2043"},{"key":"R1622CEGJCDCG","doi-asserted-by":"crossref","unstructured":"Adle-Biassette H, Chretien F, Wingertsmann L, Hery C, Ereau T, Scaravilli F, Tardieu M, Gray F: Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 1999; 25:123\u2013133","DOI":"10.1046\/j.1365-2990.1999.00167.x"},{"key":"R1622CEGBEGAC","doi-asserted-by":"crossref","unstructured":"Volkow N, Chang L, Wang G-J, Fowler J, Franceschi D, Sedler M, Gatley S, Miller E, Hitzemann R, Ding Y-S, Logan J: Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 2001; 21:9414\u20139418","DOI":"10.1523\/JNEUROSCI.21-23-09414.2001"},{"key":"R1622CEGBDJFH","doi-asserted-by":"crossref","unstructured":"Batchelor P, Liberatore G, Wong J, Porritt M, Frerichs F, Donnan G, Howells D: Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 1999; 19:1708\u20131716","DOI":"10.1523\/JNEUROSCI.19-05-01708.1999"},{"key":"R1622CEGBABGC","doi-asserted-by":"crossref","unstructured":"Cloak CC, Chang L, Ernst T, Barr MC, Huitron-Resendiz S, Sanchez-Alavez M, Phillips TR, Henriksen S: Methamphetamine and AIDS: 1HMRS studies in a feline model of human disease. J Neuroimmunol 2004; 147:16\u201320","DOI":"10.1016\/j.jneuroim.2003.10.009"},{"key":"R1622CEGGCHCG","doi-asserted-by":"crossref","unstructured":"Power C, Moench T, Peeling J, Kong PA, Langelier T: Feline immunodeficiency virus causes increased glutamate levels and neuronal loss in brain. Neuroscience 1997; 77:1175\u20131185","DOI":"10.1016\/S0306-4522(96)00531-3"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.162.2.361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T02:03:40Z","timestamp":1722391420000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.162.2.361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,1]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2,1]]}},"alternative-id":["10.1176\/appi.ajp.162.2.361"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.162.2.361","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,1]]}}}